These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8581759)
1. [Age as a factor in dose-response relationship of drugs]. Gundert-Remy U Z Gerontol Geriatr; 1995; 28(6):408-14. PubMed ID: 8581759 [TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic basis for altered drug action in the elderly. Roberts J; Tumer N Clin Geriatr Med; 1988 Feb; 4(1):127-49. PubMed ID: 3278786 [TBL] [Abstract][Full Text] [Related]
3. Drug therapy in the elderly. Turnheim K Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacotherapy in the aged]. Huber W; Turnheim K Wien Klin Wochenschr; 1987 Mar; 99(6):173-80. PubMed ID: 3590798 [TBL] [Abstract][Full Text] [Related]
5. [Use of opioids in the elderly -- pharmacokinetic and pharmacodynamic considerations]. Freye E; Levy JV Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Sep; 39(9):527-37. PubMed ID: 15334329 [TBL] [Abstract][Full Text] [Related]
6. Principles of drug therapy in geriatric patients. Sloan RW Am Fam Physician; 1992 Jun; 45(6):2709-18. PubMed ID: 1595518 [TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
9. Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly. Felix S; Sproule BA; Hardy BG; Naranjo CA J Clin Psychopharmacol; 2003 Oct; 23(5):471-8. PubMed ID: 14520124 [TBL] [Abstract][Full Text] [Related]
10. [Peculiarities of drug therapy in the elderly]. Zeeh J; Platt D Fortschr Med; 1993 Jan; 111(3):33-6. PubMed ID: 8444392 [TBL] [Abstract][Full Text] [Related]
11. [Drug interactions and the elderly]. Le Jeunne C; Hugues FC Therapie; 1995; 50(3):247-52. PubMed ID: 7667808 [TBL] [Abstract][Full Text] [Related]
12. [Geriatric pharmacology. Pharmacokinetics and pharmacodynamics in the elderly. Problems with geriatric and nootropic drugs]. Turnheim K Wien Klin Wochenschr; 1995; 107(12):349-56. PubMed ID: 7631505 [TBL] [Abstract][Full Text] [Related]
13. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
14. Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities. Mercier C; Ciccolini J; Pourroy B; Fanciullino R; Duffaud F; Digue L; Tranchand B; Monjanel-Mouterde S; Guillet P; Nicoara A; Baciuchka M; Bagarry-Liegey D; Lacarelle B; Noble A; Durand A; Favre R Ther Drug Monit; 2006 Apr; 28(2):212-8. PubMed ID: 16628133 [TBL] [Abstract][Full Text] [Related]
15. Age-related changes in pharmacokinetics: predictability and assessment methods. Perucca E Int Rev Neurobiol; 2007; 81():183-99. PubMed ID: 17433924 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic crisis in the elderly. ElDesoky ES Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 1. Tsujimoto G; Hashimoto K; Hoffman BB Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):13-26. PubMed ID: 2663734 [TBL] [Abstract][Full Text] [Related]
18. Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged. Schumacher GE Am J Hosp Pharm; 1980 Apr; 37(4):559-62. PubMed ID: 6990755 [TBL] [Abstract][Full Text] [Related]